Join us July 11, 2012 as Aaron Kolwalski, Ph.D shares the latest in T1D research. The program will be held live at Corporate College East (4400 Richmond Road, Warrensville Hts., OH 44128) and simulcast at The University Center, Kent State University (6000 Frank Avenue NW, North Canton, OH 44720). Click here for more details and registration information.
Aaron J. Kowalski, Ph.D., is an internationally recognized expert in the area of diabetes technologies and has been a leader of JDRF’s Artificial Pancreas Project, a multi-million dollar initiative that began in 2005 to accelerate the progress toward a closed-loop automated insulin-delivery system. JDRF established the Artificial Pancreas Consortium to fund doctors and researchers across the world to advance this revolutionary way to treat and manage type 1 diabetes. Today JDRF is poised to translate research into the first steps toward real treatment options, by partnering with Animas, a Johnson & Johnson company that manufactures insulin delivery and glucose management systems, to develop a first-generation artificial pancreas. Currently there are clinical out-patient trials in Europe and similar ones are scheduled to start in the US later this year.
Here is a webcast of JDRF’s Dr. Aaron Kowalski describing the Artificial Pancreas Project and JDRF’s partnerships with Animas, DexCom, and BD.
» Follow @JDRFneo